emetine has been researched along with daunorubicin in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (33.33) | 18.7374 |
1990's | 2 (16.67) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Kuhn, E; Mono, G | 1 |
Furusawa, E; Furusawa, S; Lee, JY; Suzuki, N | 1 |
Bouhour, JB; Chareyre, M; Godin, JF; Nicolas, G; Rozo, L | 1 |
Ayala, P; Orozco, E; Samuelson, J; Wirth, D | 1 |
Bégueret, J; Chamla, Y | 1 |
Barratt, G; Døskeland, SO; Herfindal, L; Myhren, L; Nicolas, V; Nilssen, IM | 1 |
1 review(s) available for emetine and daunorubicin
Article | Year |
---|---|
[Cardiotoxic effects of drugs and various other substances. A review].
Topics: Adrenergic Agonists; Amphetamine; Antimony; Arrhythmias, Cardiac; Arsenic Poisoning; Catecholamines; Chloroquine; Clofibrate; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Emetine; Endomyocardial Fibrosis; Heart; Heart Arrest; Heart Block; Humans; Hypertension; Lithium; Methysergide; Myocarditis; Myofibrils; Psychotropic Drugs | 1978 |
11 other study(ies) available for emetine and daunorubicin
Article | Year |
---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Combination chemotherapy of Rauscher leukemia and ascites tumors by narcissus alkaloid with standard drugs and effect on cellular immunity.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Blood Cells; Carcinoma, Ehrlich Tumor; Carmustine; Cells, Cultured; Cyclophosphamide; Dactinomycin; Daunorubicin; Drug Synergism; Drug Therapy, Combination; Emetine; Leukemia, Experimental; Leukemia, Lymphoid; Methotrexate; Mice; Mice, Inbred BALB C; Plants, Medicinal; Rauscher Virus; Spleen; Streptonigrin; Vincristine | 1975 |
[The heart and drug poisoning, excluding cardiologic treatments].
Topics: Daunorubicin; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Emetine; Heart; Humans; Lithium; Myocarditis | 1978 |
Entamoeba histolytica: physiology of multidrug resistance.
Topics: Animals; Colchicine; Cross Reactions; Dactinomycin; Daunorubicin; Drug Resistance; Emetine; Entamoeba histolytica; Verapamil | 1990 |
Colchicine resistance in human cell lines. Pleiotropic phenotype and decreased membrane permeability.
Topics: Cell Line; Colchicine; Cross Reactions; Cycloheximide; Daunorubicin; Drug Resistance; Emetine; Humans; Lidocaine; Phenotype; Skin; Vinblastine; Vincristine | 1982 |
Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia.
Topics: Anthracyclines; Cell Line, Tumor; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Resistance; Emetine; Flow Cytometry; Folate Receptor 2; Humans; Leukemia, Myeloid, Acute; Light; Liposomes; Male; Methotrexate; Polyethylene Glycols; Prostatic Neoplasms; Scattering, Radiation; Tumor Suppressor Protein p53 | 2014 |